Immune Dysregulation Mimicking Systemic Lupus Erythematosus in a Patient With Lysinuric Protein Intolerance: Case Report and Review of the Literature.

Frontiers in Pediatrics
Josefina Longeri ContrerasM Cecilia Poli

Abstract

Lysinuric protein intolerance (LPI) is an inborn error of metabolism caused by defective transport of cationic amino acids in epithelial cells of intestines, kidneys and other tissues as well as non-epithelial cells including macrophages. LPI is caused by biallelic, pathogenic variants in SLC7A7. The clinical phenotype of LPI includes failure to thrive and multi-system disease including hematologic, neurologic, pulmonary and renal manifestations. Individual presentations are extremely variable, often leading to misdiagnosis or delayed diagnosis. Here we describe a patient that clinically presented with immune dysregulation in the setting of early-onset systemic lupus erythematosus (SLE), including renal involvement, in whom an LPI diagnosis was suspected post-mortem based on exome sequencing analysis. A review of the literature was performed to provide an overview of the clinical spectrum and immune mechanisms involved in this disease. The precise mechanism by which ineffective amino acid transport triggers systemic inflammatory features is not yet understood. However, LPI should be considered in the differential diagnosis of early-onset SLE, particularly in the absence of response to immunosuppressive therapy.

References

Feb 1, 1988·Human Genetics·D N Cooper, H Youssoufian
Jan 1, 1995·Archives of Gynecology and Obstetrics·N TakayamaT Kubo
Jan 1, 1994·Journal of Inherited Metabolic Disease·M CanditoP Chambon
Jan 1, 1993·Journal of Inherited Metabolic Disease·K PartoO Simell
Apr 1, 1996·Journal of Clinical Pathology·D T McManusA H Love
Jan 1, 1996·Journal of Inherited Metabolic Disease·A HasanoğluG Biberoğlu
Mar 1, 1996·European Journal of Pediatrics·J B de KlerkG M Mancini
Feb 21, 1998·The Journal of Pediatrics·M A ReinosoS J Schwarzenberg
Mar 21, 1998·European Journal of Pediatrics·T KamodaN Nakamura
May 19, 1998·Journal of Inherited Metabolic Disease·C Dionisi-ViciM Caniglia
May 19, 1998·Journal of Inherited Metabolic Disease·M LukkarinenO Simell
Jan 13, 2000·American Journal of Human Genetics·M P SperandeoG Borsani
Aug 15, 2002·Molecular Genetics and Metabolism·Stanley H KormanAlisa Gutman
Mar 31, 2004·Lancet·M GattornoA Martini
May 7, 2005·Journal of Inherited Metabolic Disease·L MannucciC Dionisi-Vici
Oct 19, 2005·Neurology India·N V Ahsan MoosaAnand Kumar
Jun 16, 2006·European Journal of Pediatrics·Valentina EspositoMariacarolina Salerno
Jul 27, 2006·Journal of Inherited Metabolic Disease·L GömezM A Vilaseca
Jan 17, 2007·Metabolism: Clinical and Experimental·Laura M TannerOlli Simell
Mar 28, 2007·Orphanet Journal of Rare Diseases·Michele CerutiMaurizio Luisetti
May 29, 2007·Journal of Inherited Metabolic Disease·M A BenningaB T Poll-The
Aug 2, 2007·Journal of Applied Genetics·Loreta CimbalistieneVaidutis Kucinskas
Aug 22, 2008·European Journal of Human Genetics : EJHG·Mariona Font-LlitjósVirginia Nunes
Nov 30, 2010·Orphanet Journal of Rare Diseases·Amelia BarilliValeria Dall'Asta
Feb 11, 2011·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Gianfranco SebastioGeneroso Andria
Jul 1, 2011·Journal of Pediatric Gastroenterology and Nutrition·Marwan ShinawiAlexander Weymann
Feb 14, 2012·Molecular Genetics and Metabolism·Amelia BarilliValeria Dall'Asta
Mar 10, 2012·Molecular Genetics and Metabolism·Hélène Ogier de BaulnyCarlo Dionisi-Vici
Jan 30, 2013·European Journal of Pediatrics·Anasufiza HabibLock-Hock Ngu

❮ Previous
Next ❯

Software Mentioned

ClinVar
cBioPortal mapper

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.